Informational Conference Call: March 7, 2013 at 12pm US ESTPre-Proposals Due: April 3, 2013To participate in the call and receive call-in details, please RSVP via email to email@example.com.Synuclein Therapeutic Acceleration Program (SynTAP 2013)MJFF seeks to aggressively move therapeutic compounds and biologics targeting alpha-synuclein into clinical testing by funding mid to late-stage pre-clinical development work. Studies should be designed to obtain data required for Investigational New Drug application submission, and for future clinical testing of the therapeutic.
The Michael J. Fox Foundation Launches New Funding Opportunities For Parkinson's Research
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.